FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Imprimis NJOF Moxifloxacin 0 Recall

Moxifloxacin 0

Imprimis NJOF, LLC · Ledgewood, NJ

Risk level
Class II
Reported by FDA
Jun 5, 2024
Recall ID
D-0515-2024
Check your lot numberHow we source this data

Summary

Imprimis NJOF recalled Moxifloxacin 0 starting May 14, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0515-2024 on Jun 5, 2024. Reason: Lack of Assurance of Sterility. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility

Product description

Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-509-08

Lot numbers, UPCs & expiration codes

Lot #: 23OCT013, Exp. Date 10/10/2024

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0515-2024
Classification
Class II
Status
Ongoing
Recall initiated
May 14, 2024
FDA report date
Jun 5, 2024
Quantity
18,980 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Imprimis NJOF, LLC

Original FDA data

Every field from FDA enforcement report D-0515-2024, exactly as published.

Show all FDA fields
City
Ledgewood
State
NJ
Status
Ongoing
Country
United States
Event ID
94551
Address
1705 Route 46 Ste 6B
Code information
Lot #: 23OCT013, Exp. Date 10/10/2024
Postal code
07852-9720
Report date
Jun 5, 2024
Product type
Drugs
Recall number
D-0515-2024
Classification
Class II
Recalling firm
Imprimis NJOF, LLC
Product quantity
18,980 vials
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-509-08
Distribution pattern
Nationwide within the United States
Recall initiation date
May 14, 2024
Center classification date
May 29, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0515-2024, published Jun 5, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls